{"nct_id":"NCT02038647","title":"Phase 2 Study of Alisertib (MLN8237) in Combination With Paclitaxel Versus Placebo in Combination With Paclitaxel as Second Line Therapy for Small Cell Lung Cancer (SCLC)","status":"COMPLETED","status_verified_date":"2018-11","start_date":"2014-05-12","start_date_type":"ACTUAL","primary_completion_date":"2016-01-03","primary_completion_date_type":"ACTUAL","completion_date":"2017-07-10","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["TAK"]}